Smadja, David M <br/><br/>
PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Nov 2005 
 - 2321-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4636 
<br/><br/><label>Standard No.: </label>10.1161/01.ATV.0000184762.63888.bd  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actin Cytoskeleton--metabolism<br/>Antibodies--pharmacology<br/>Antigens, CD34--metabolism<br/>Cell Division--physiology<br/>Cell Movement--physiology<br/>Cell Survival--physiology<br/>Cells, Cultured<br/>Chemokine CXCL12<br/>Chemokines, CXC--antagonists & inhibitors<br/>Cytokines--genetics<br/>Endothelial Cells--cytology<br/>Fetal Blood--cytology<br/>Gene Expression--physiology<br/>Hematopoietic Stem Cells--cytology<br/>Humans<br/>In Vitro Techniques<br/>Neovascularization, Physiologic--physiology<br/>Receptor, PAR-1--genetics<br/>Receptors, CXCR4--antagonists & inhibitors<br/>Up-Regulation